Tubidy MP3 & MP4

En popüler MP3 müziklerinizi ve MP4 videolarınızı ücretsiz indirin. Geniş bir multimedya içeriği seçkisini keşfedin ve sorunsuz indirmelerin tadını çıkarın.

Peptide Drug Challenges through Pre-ANDA Processes & Case Studies (6of39) Complex Generics 2018
Peptide Drug Challenges through Pre-ANDA Processes & Case Studies (6of39) Complex Generics 2018
|
Yükleniyor...
Lütfen bekleyiniz...
Type
Size

İlgili Videolar

Peptide Drug Challenges through Pre-ANDA Processes & Case Studies (6of39) Complex Generics 2018

Peptide Drug Challenges through Pre-ANDA Processes & Case Studies (6of39) Complex Generics 2018

|
Pre-ANDA review: Office of Pharmaceutical Quality (OPQ) (4of39) Complex Generics 2018

Pre-ANDA review: Office of Pharmaceutical Quality (OPQ) (4of39) Complex Generics 2018

|
Questions and Panel Discussion (5of39) Complex Generics 2018

Questions and Panel Discussion (5of39) Complex Generics 2018

|
BE Approaches for Long Acting Drug Products (14of35) Complex Generics – Sep. 25-26, 2019

BE Approaches for Long Acting Drug Products (14of35) Complex Generics – Sep. 25-26, 2019

|
Pre-ANDA Program

Pre-ANDA Program

|
Questions and Panel Discussion (20of39) Complex Generics 2018

Questions and Panel Discussion (20of39) Complex Generics 2018

|
Non-clinical Evaluation of Immunogenicity Risk of Generic Complex Peptide Products

Non-clinical Evaluation of Immunogenicity Risk of Generic Complex Peptide Products

|
Pre-ANDA Program Update and Tips for Success – OPQ Perspective

Pre-ANDA Program Update and Tips for Success – OPQ Perspective

|
Best Practices for Conducting Bioequivalence Studies (16of27) Generic Drugs Forum 2018

Best Practices for Conducting Bioequivalence Studies (16of27) Generic Drugs Forum 2018

|
Andrew Isidoridy: Evaluating immunogenicity risk of complex peptide products

Andrew Isidoridy: Evaluating immunogenicity risk of complex peptide products

|
Filing Review Basics – Examples of Refuse-to-Receive (RTR) (15of27) Generic Drugs Forum 2018

Filing Review Basics – Examples of Refuse-to-Receive (RTR) (15of27) Generic Drugs Forum 2018

|
Panel Questions and Discussion (35of35) Complex Generics – Sep. 25-26, 2019

Panel Questions and Discussion (35of35) Complex Generics – Sep. 25-26, 2019

|
Panel Discussion Orally Inhaled and Nasal Drug Products (38of39) Complex Generics 2018

Panel Discussion Orally Inhaled and Nasal Drug Products (38of39) Complex Generics 2018

|
Synthetic Therapeutic Peptide APIs: Documentation for API Sameness & Related Impurities

Synthetic Therapeutic Peptide APIs: Documentation for API Sameness & Related Impurities

|
Keynote with Sally Choe (1of35) Complex Generics – Sep. 25-26, 2019

Keynote with Sally Choe (1of35) Complex Generics – Sep. 25-26, 2019

|
Complex Product Development (3of28) Generic Drugs Forum – Apr. 3-4, 2019

Complex Product Development (3of28) Generic Drugs Forum – Apr. 3-4, 2019

|
Assessment of Complex Drug Product – Physicochemical Characteristics to Support In Vitro BE Studies

Assessment of Complex Drug Product – Physicochemical Characteristics to Support In Vitro BE Studies

|
Peptide Bioanalysis Webinar

Peptide Bioanalysis Webinar

|
Narasimha Rao: FDA recommendations on immunogenicity risk assessment for synthetic peptide drugs

Narasimha Rao: FDA recommendations on immunogenicity risk assessment for synthetic peptide drugs

|
Bachem capabilities to address the new FDA guideline for synthetic peptides

Bachem capabilities to address the new FDA guideline for synthetic peptides

|